Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic
  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:

Creative Biolabs Provides Neutralization Assay Service for Virological Studies

By: Get News
With proven ability in antibody discovery service, Creative Biolabs is working on providing virology researchers with ViroAntibodies of high quality and neutralization assay services to support research advancements.

New York, USA – July 21, 2022 – Antibody neutralization of viruses is a common medical phenomenon. Although neutralization is believed to have the ability to eliminate or reduce viral replication, it does not imply a particular mechanism of interference with the replication process. Currently, plenty of antibody therapies based on neutralization mechanisms have emerged for the treatment of various infectious diseases, endocrine disorders, and many others. Meanwhile, the neutralization assay is specially used for routine validating and measuring the therapeutic action of such antibodies. The Viroantibody neutralization assay service from Creative Biolabs promises to give customers the most reliable results, giving them complete confidence in their virological research.

* Pseudovirus Neutralization Assay

As an artificially made recombinant viral particle, pseudovirus often possesses a similar conformation as a live virus and can mimic viral infection. Pseudoviruses have become useful virological tools because of their security and versatility, especially for emerging and re-emerging viruses such as SARS-CoV-2. Based on the VSV pseudovirus production system, Creative Biolabs has developed a pseudovirus-based neutralization assay. In addition to neutralization assay, it also supports neutralization antibody products, meeting the study needs of clients worldwide.

* Anti-Coxsackievirus Antibodies

Coxsackievirus is part of the enterovirus family. Coxsackievirus B3 (CVB3) has emerged as an active pathogen in myocarditis, aseptic meningitis, hand, foot, and mouth disease (HFMD), and pancreatitis, posing a significant public health burden. Currently, anti-coxsackievirus antibodies have been extensively used as essential elements in diagnostic assays for disease screening and research. With years of experience and professional services, Creative Biolabs provides high-quality antibody development services targeting different proteins against diverse serotypes of coxsackieviruses for our global clients. In addition to the ready-to-use antibodies, the custom antibody development service is available to satisfy clients’ research target that goes beyond the in-stock product catalog.

* Anti-Cytomegalovirus Antibodies

Cytomegalovirus (CMV) is a common virus that can affect people of all ages and spreads mainly through close contact with someone who already got infected or through body fluids including saliva, blood, urine, semen, and breast milk. Creative Biolabs can provide bulk CMV antibody products against various protein targets to meet customer goals, including but not limited to gB (envelop glycoprotein B), gH (envelop glycoprotein H), IE (major immediate-early protein), and CMV.

Access more information about antibody neutralization assays at Creative Biolabs at https://viroantibody.creative-biolabs.com.

About Creative Biolabs

As a leading professional biotech company specializing in antibody discovery, Creative Biolabs provides a wide range of neutralizing antibody products of high specificity, customized antibody development services, and various assays for neutralizing antibody discovery.

Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Phone: 1-631-830-6441
Country: United States
Website: https://viroantibody.creative-biolabs.com

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.